Babu, M. and C. J., J. 2017. Rucaparib: a PARP inhibitor for the treatment of advanced ovarian cancer. International Journal of Basic & Clinical Pharmacology. 6, 4 (Mar. 2017), 1018–1019. DOI:https://doi.org/10.18203/2319-2003.ijbcp20171125.